Results 181 to 190 of about 69,773 (297)

Clinico-genomic characterization of RAS-mutant acute myeloid leukemia. [PDF]

Ann Hematol
Yuan R, Xie Y, Miron PM, Higgins AW, Hutchinson L, Cerny J, Patel SA.   +6 more
europepmc   +1 more source

Progress report on the European electronic communications market 2008 (14th report). Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions. COM (2009) 140 final, 30 July 2009 [PDF]

, 2009

core  

Amido‐Amine Co(II) Precursor‐Based Atomic/Molecular Layer Deposition Processes for Cobalt‐Organic Thin Films and Their Thermal Conversion to CoO Thin Films

Advanced Materials Technologies, Volume 11, Issue 9, 6 May 2026.
Three new atomic/molecular layer deposition processes are developed for Co‐organic thin films using a promising all‐nitrogen‐coordinated cobalt precursor. The study examines film growth, reaction mechanisms, chemical stability, and decomposition pathways of the resulting films through extensive characterization techniques and DFT calculations ...
Topias Jussila, Jorit Obenlüneschloß, Ji Liu, Olga Partanen, Sami Vasala, Detlef Rogalla, Pieter Glatzel, Michael Nolan, Anjana Devi, Maarit Karppinen   +9 more
wiley   +1 more source

The Prognostic Significance of KRAS, NRAS, and BRAF Mutations in Colorectal Cancer: A Systematic Review and Meta-Analysis. [PDF]

Clin Med Insights Oncol
Oyelami M, Mgbeke O, Obadiah AA, Egbeyemi A, Marshall E.   +4 more
europepmc   +1 more source

Dysregulation of the PATZ1/CTCF Balance Silences ZBTB20 to Drive Melanoma Progression

Advanced Science, Volume 13, Issue 26, 8 May 2026.
This study uncovers a new oncogenic mechanism in melanoma. The transcription factor PATZ1 competes with the architectural protein CTCF for DNA binding, thereby disrupting a specific chromatin loop and silencing the tumor suppressor ZBTB20. This event unleashes the pro‐tumorigenic PMEPA1‐p38‐STAT1 signaling axis, promoting cancer progression.
Chaowei Deng, Shuang Cai, Chen Guo, Shaker Khan, Lefan Liu, Qiong Tian, Zhiyuan Ma, Jian Zhang, Lingyu Zhao   +8 more
wiley   +1 more source

Primary malignant melanoma of the uterine cervix: a case report of aggressive progression despite multimodal therapy. [PDF]

Front Oncol
Yu Q.
europepmc   +1 more source

NRAS NP_002515.1:p.G13S [PDF]

, 2020
openaire   +1 more source

European electronic communications regulation and markets 2005 (11th report). Communication from the Commission to the Council, the European Parliament, the European Economic and Social Committee and the Committee of the Regions. COM (2006) 68 final, 20 February 2006 [PDF]

, 2006

core  

Selinexor and Venetoclax Combination in Patients With Relapsed or Refractory Acute Myeloid Leukemia

American Journal of Hematology, Volume 101, Issue 5, Page 1019-1024, May 2026.
ABSTRACT Preclinical studies showed a synergistic antileukemia activity with combination of selective XPO1 inhibitor selinexor (SEL) and venetoclax (VEN), with potential to overcome VEN resistance by reducing the anti‐apoptotic protein MCL1. In an investigator‐sponsored, open‐label, phase Ib study (NCT03955783), adult patients with relapsed or ...
Somedeb Ball, Farrukh T. Awan, Ben K. Tomlinson, Tess Stopczynski, Melissa A. Fischer, Zhiguo Zhao, Kateryna Fedorov, Ashwin Kishtagari, Sanjay R. Mohan, Gregory D. Ayers, Michael T. Byrne, Michael R. Savona   +11 more
wiley   +1 more source

Characterization of intestinal immune responses in generalized human and murine lipodystrophy. [PDF]

J Clin Invest
Letizia M, Omar T, Weidner P, Jakob MO, Freise I, Krug SM, Löscher BS, Rosati E, Obermayer B, Gamez-Belmonte R, Hecker J, Ziegler JF, Weixler B, Asbach P, Kunkel D, Stumvoll M, Miehle K, Becker C, Klose CS, Glauben R, Beule D, Kühl AA, Conrad T, Tacke F, Wirtz S, Franke A, Sanders AD, Siegmund B, Weidinger C.   +28 more
europepmc   +1 more source